How to guide the selection of patients for trimodality therapy: the case for tumor immune and stromal signature.
Sign Up to like & getrecommendations! Published in 2019 at "Translational andrology and urology"
DOI: 10.21037/tau.2019.05.10
Abstract: Bladder cancer (BCa) is the 7th most common cancer in men, with an estimated 81,190 new cases and 17,240 deaths in 2018 in the USA (1). Radical cystectomy (RC) with cisplatin-based neoadjuvant chemotherapy (NAC) is… read more here.
Keywords: guide selection; therapy; patients trimodality; selection patients ... See more keywords